BET bromodomain inhibition suppresses adipogenesis in mice

Purpose We recently reported that inhibition of BET bromodomain suppresses adipogenesis in vitro. In the present study we aimed to address whether BET bromodomain inhibition can suppress adipogenesis in vivo. Methods Brd4 fl/fl mice were crossed with B6.Cg-Tg( Fabp4 -cre)1Rev/J mice to generate Brd4...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine 2020, Vol.67 (1), p.264-267
Hauptverfasser: Duan, Qiong, Wu, Pei, Liu, Zhenzhen, Xia, Fan, Zhu, Lingyan, Zheng, Zeqi, Yang, Tianlun, Qi, Jun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose We recently reported that inhibition of BET bromodomain suppresses adipogenesis in vitro. In the present study we aimed to address whether BET bromodomain inhibition can suppress adipogenesis in vivo. Methods Brd4 fl/fl mice were crossed with B6.Cg-Tg( Fabp4 -cre)1Rev/J mice to generate Brd4 fl/+ / Fabp4 -cre mice. We used high fat diet (HFD, 45% fat) mice treated with vehicle (DMSO) or JQ1 (intraperitoneal, IP injection, 50 mg/kg/day), respectively, for 6 weeks. Body weight was measured once a week. Dual-energy X-ray absorptiometry was determined and brown adipose tissue was harvested at the end of the experiment. Results Partial deletion of Brd4 leads to the lower body weight. JQ1 treatment further confirmed that BET bromodomain inhibition suppresses body weight gain and decreases white adipose depots compared with the control mice. In addition, JQ1 treatment reduces the size of brown adipose tissue and impairs its thermogenesis. Conclusions BET bromodomain inhibition suppresses adipogenesis in the mice.
ISSN:1355-008X
1559-0100
DOI:10.1007/s12020-019-02115-4